NKG2A has significant implications in various diseases, including cancer, autoimmune disorders, and infectious diseases. In the context of cancer, high expression of NKG2A on NK cells can inhibit their ability to destroy tumor cells, making it a target for cancer immunotherapy. Blocking NKG2A can enhance the anti-tumor activity of NK cells and CTLs, providing a therapeutic approach to boost the immune response against cancers.
